Stepping back to the previous dose for an additional four weeks resolves most cases
Intestinal cells can convert glutamine into glutamate, which is crucial for the usage of glutamine for energy purposes (88)
Red blood cell membrane-camouflaged nanoparticles: a novel drug delivery system for antitumor application
If gastrointestinal symptoms become intolerable, healthcare providers may recommend temporarily pausing dose escalation, maintaining the current dose longer before increasing, or even reducing to a previous dose until symptoms improve
To analyze MRS data, we used the LCModel with a basis set of simulated spectra comprising the following 20 metabolites: Aspartate (Asp), phosphocholine (PCh), creatine (Cr), phosphocreatine (PCr), GABA, Gln, Glu, glutathione (GSH), glycine (Gly), mI, lactate (Lac), NAA, scyllo-inositol (Scyllo), taurine (Tau), glucose (Glc), N-acetylaspartylglutamate (NAAG), glycerophosphocholine (GPC), phosphorylethanolamine (PE), Serine (Ser), and MM (Fig
